Published • loading... • Updated
Is a New Treatment for Cancer on the Horizon? Moderna CEO Explains
Summary by cascadepbs.org
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
Drugmakers Moderna and Merck have announced that their mRNA-based vaccine against melanoma (the most common skin cancer) works excellently.
Can One Cancer Vaccine Platform Work Across Different Cancers?
Moderna and Merck aren't stopping with melanoma. They're testing the same personalized cancer vaccine approach in multiple cancers, including lung, bladder and kidney cancer. But there's an important catch: the detailed Phase 3 results aren't available yet. Melanoma may be the easiest place for th
Combined with Keytruda immunotherapy, from Merck's laboratory, a new personalized messenger RNA treatment, developed by Moderna, has improved the survival without recurrence of patients with advanced melanoma.
Coverage Details
Total News Sources4
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
